The clinical trial is the longest finalized study of tirzepatide so far.
Lilly has only shared top-line datathe main takeaways from the study.
The full data will be published in a peer-reviewed journal and presented at amedical conferencein November.
Bloomberg / Contributor / Getty Images
But there are downsides to the medications, too, including cost and sometimes uncomfortable side effects.
A health provider can help you weigh the pros and cons of the drugs.
Centers for Disease Control and Prevention.Prediabetes your chance to prevent punch in 2 diabetes.
2020;63(7):1324-1332. doi:10.1007/s00125-020-05140-5
